Our implant syringe has been successfully registered at the Chinese National Medical Products Administration (NMPA).
Our device is available with a depot for one or three months and both variants have been included in the database of the “Center for Drug Evaluation (CDE) which are valid from now on.
We are very pleased that our implant syringe can now also be used for treatments against, for example, breast and prostate cancer in China and that we can thus help even more patients. In addition, it can be used in veterinary medicine or for hormonal long-term contraception.
For detailed information, see Implant Syringe – GAPLAST.
The road was long (2,5 years to be exact!), but it was definitely worth it!
Gaplast Implant Syringe à Developed & Produced in Germany | Bavaria | Altenau & Peiting.
Do you have any questions about it? Do not hesitate and contact us at firstname.lastname@example.org.